Time dependency of uterine effects of naringenin type phytoestrogens in vivo

Molecular and Cellular Endocrinology

Volumn 294, Issue 1-2, 2008, Pages 92-99

  Zierau, Oliver ^a   Kretzschmar, Georg ^a   Möller, Frank ^a   Weigt, Carmen ^a   Vollmer, Günter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

6 (1,1 Dimethylallyl)naringenin; 8 Prenylnaringenin; Estradiol; Estrogen receptor; Phytoestrogens; Uterotrophy

Indexed keywords

6 (1,1 DIMETHYLALLYL)NARINGENIN; 8 PRENYLNARINGENIN; CLUSTERIN; CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; NARINGENIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; UTERUS WEIGHT;

ANIMALS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FLAVANONES; GENE EXPRESSION REGULATION; HUMANS; ORGAN SIZE; OVARIECTOMY; PHYTOESTROGENS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UTERUS;

EID: 53649108356     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.08.008     Document Type: Article

References (37)

1. Bennetts H.W., Underwood E.J., and Shier F.L. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. Vet. J. 22 (1946) 2-12
2. Brown N.M., and Setchell K.D. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest. 81 (2001) 735-747
3. Byers M., Kuiper G.G., Gustafsson J.A., and Park-Sarge O.K. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol. Endocrinol. 11 (1997) 172-182
4. Coleman K.M., and Smith C.L. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front. Biosci. 6 (2001) D1379-1391
5. Cos P., De Bruyne T., Apers S., Berghe D.V., Pieters L., and Vlietinck A.J. Phytoestrogens: recent developments. Planta Med. 69 (2003) 589-599
6. Diel P., Thomae R.B., Caldarelli A., Zierau O., Kolba S., Schmidt S., Schwab P., Metz P., and Vollmer G. Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats. Planta Med. 70 (2004) 39-44
7. Gester S., Metz P., Zierau O., and Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin by europium(III)-catalyzed Claisen rearrangement. Tetrahedron 57 (2001) 1015-1018
8. Ito K. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. Tohoku J. Exp. Med. 212 (2007) 1-12
9. Jakacka M., Ito M., Martinson F., Ishikawa T., Lee E.J., and Jameson J.L. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16 (2002) 2188-2201
10. Kitaoka M., Kadokawa H., Sugano M., Ichikawa K., Taki M., Takaishi S., Iijima Y., Tsutsumi S., Boriboon M., and Akiyama T. Prenylflavonoids: a new class of non-steroidal phytoestrogen (part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med. 64 (1998) 511-515
11. Krebs E.E., Ensrud K.E., MacDonald R., and Wilt T.J. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet. Gynecol. 104 (2004) 824-836
12. Kretzschmar G., Vollmer G., Schwab P., Tischer S., Metz P., and Zierau O. Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4′-acetate on the estrogen signaling pathway in vivo and in vitro. J. Steroid Biochem. Mol. Biol. 107 (2007) 114-119
13. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5925-5930
14. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
15. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 (2000) 311-317
16. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 431-443
17. Milligan S., Kalita J., Pocock V., Heyerick A., De Cooman L., Rong H., and De Keukeleire D. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123 (2002) 235-242
18. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., and De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 84 (1999) 2249-2252
19. Moller F., Zierau O., Jandausch A., Rettenberger R., Kaszkin-Bettag M., and Vollmer G. Subtype-specific activation of estrogen receptors by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds in U2OS human osteosarcoma cells. Phytomedicine 14 (2007) 716-726
20. Nagata C., Takatsuka N., Kawakami N., and Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am. J. Epidemiol. 153 (2001) 790-793
21. O'Brien J.E., Peterson T.J., Tong M.H., Lee E.J., Pfaff L.E., Hewitt S.C., Korach K.S., Weiss J., and Jameson J.L. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. J. Biol. Chem. 281 (2006) 26683-26692
22. Ososki A.L., and Kennelly E.J. Phytoestrogens: a review of the present state of research. Phytother. Res. 17 (2003) 845-869
23. Rad M., Humpel M., Schaefer O., Schoemaker R.C., Schleuning W.D., Cohen A.F., and Burggraaf J. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 62 (2006) 288-296
24. Ray A., Prefontaine K.E., and Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269 (1994) 12940-12946
25. Roelens F., Heldring N., Dhooge W., Bengtsson M., Comhaire F., Gustafsson J.A., Treuter E., and De Keukeleire D. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta. J. Med. Chem. 49 (2006) 7357-7365
26. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
27. Saunders P.T., Maguire S.M., Gaughan J., and Millar M.R. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J. Endocrinol. 154 (1997) R13-16
28. Schaefer O., Humpel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 (2003) 359-360
29. Seo E.K., Silva G.L., Chai H.B., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Pezzuto J.M., and Kinghorn A.D. Cytotoxic prenylated flavanones from Monotes engleri. Phytochemistry 45 (1997) 509-515
30. Singleton D.W., and Khan S.A. Xenoestrogen exposure and mechanisms of endocrine disruption. Front. Biosci. 8 (2003) s110-118
31. Tokalov S.V., Henker Y., Schwab P., Metz P., and Gutzeit H.O. Toxicity and cell cycle effects of synthetic 8-prenylnaringenin and derivatives in human cells. Pharmacology 71 (2004) 46-56
32. Vollmer G., and Zierau O. What are phytoestrogens and phyto-SERMS. Pharm. Unserer. Zeit. 33 (2004) 378-383
33. Whitten P.L., and Patisaul H.B. Cross-species and interassay comparisons of phytoestrogen action. Environ. Health Perspect. 109 Suppl. 1 (2001) 5-20
34. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270 (1999) 41-49
35. Zierau O., Geis R.B., Tischer S., Schwab P., Metz P., and Vollmer G. Uterine effects of the phytoestrogen 6-(1,1-dimethylallyl)naringenin in rats. Planta Med. 70 (2004) 590-593
36. Zierau O., Gester S., Schwab P., Metz P., Kolba S., Wulf M., and Vollmer G. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med. 68 (2002) 449-451
37. Zierau O., Morrissey C., Watson R.W., Schwab P., Kolba S., Metz P., and Vollmer G. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med. 69 (2003) 856-858